For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260312:nRSL2965Wa&default-theme=true
RNS Number : 2965W Primary Health Properties PLC 12 March 2026
Primary Health Properties PLC
(Incorporated in the United Kingdom)
Company Number: 3033634
LSE Share Code: PHP
JSE Share Code: PHP
ISIN Code: GB00BYRJ5J14
LEI: 213800Y5CJHXOATK7X11
("PHP" or the "Company")
Notice of Preliminary Results
Primary Health Properties PLC (LSE: PHP), the UK's leading investor in
critical healthcare infrastructure, will announce its preliminary results for
the year ended 31 December 2025 on Tuesday 17 March 2026.
A virtual presentation for analysts and investors will be held on 17 March
2026 at 9.00am (11.00am SAST) via a live webcast and conference call facility.
Following the presentation there will be a managed questions and answers
session.
The presentation will be accessible via live video webcast and a live
conference call facility: Webcast: https://brrmedia.news/PHP_FY_25
(https://brrmedia.news/PHP_FY_25)
Telephone: UK-wide: +44 (0) 33 0551 0200
Telephone: South Africa toll free: 0 800 980 512
Password: Quote "PHP Results" when prompted
A recording of the webcast will be made available from c.1.00pm UK time
(3.00pm SAST) on 17 March 2026 on the PHP website,
https://www.phpgroup.co.uk/.
For further information contact:
Mark Davies
CEO
Richard Howell CFO
Primary Health Properties
PLC
Primary Health Properties PLC
David Purcell Investor Relations
Primary Health Properties PLC
T: +44 (0) 7921 190 136
E: david.purcell@phpgroup.co.uk
Sodali & Co Financial PR
Elly Williamson/Louisa Henry/Saskia Bottomley
T: +44 (0) 207 250 1446 E: PHP@client.sodali.com
The Company has a primary listing on the London Stock Exchange and a secondary
listing on the JSE Limited.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NOREAXDFFADKEFA
Copyright 2019 Regulatory News Service, all rights reserved